Redcliffe Labs sells Crysta IVF to MMG Group’s Moon Care to sharpen diagnostics play
Divestment marks Redcliffe’s strategic pivot toward preventive and advanced diagnostics; Crysta IVF to continue under existing leadership
Divestment marks Redcliffe’s strategic pivot toward preventive and advanced diagnostics; Crysta IVF to continue under existing leadership
With the new facility, the company underlines its commitment to meet the substantially growing demand for its MCC
She holds a Masters degree in Genetics along with a Ph.D. in Biochemistry
The newly launched centre in Mumbai is part of the company’s ambition to be present in 100 cities across the country within two years.”
New hit discovery service combines integrated DNA-Encoded Library screening, structural biology, biophysics, and X-ray crystallography
Enhanced CMC infrastructure at Cranbury site aims to improve bioavailability, streamline formulation development and support faster progression of challenging drug candidates into clinical trials
SERB has a substantial European commercial presence and a successful track record in critical care and rare disease commercialization
Paves the way for next-gen ultra-precise gas sensing
The facility supports drug discovery, biomolecular research, and the development of next-generation diagnostics
The initiative provides clearer regulatory guidance and a defined path from research in space to patient access on Earth
Subscribe To Our Newsletter & Stay Updated